| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 2.45 CAD | 0.00 (0.00%) | 2.34 - 4.68 | 0.0 |
Market data as of 12:00AM 06/19/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 2.45 |
| Day's Range | -- - -- |
| Market Cap | 127.1M |
| Avg Volume (10 Day) | 52.0K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | |
| Dividend Yield | No Dividend |
Yale-New Haven neurosurgeons verifying effective eye tumor drug delivery localization with iMRI in VISIUS® Surgical Theatre
PR Newswire - Wednesday 06/19/2013 12:14 PM ET
Tübingen Hospital experience with intraoperative MRI improves patient outcomes
PR Newswire - Wednesday 06/12/2013 11:00 AM ET
James B. Hickey, Jr. Joins IMRIS Board of Directors
PR Newswire - Thursday 05/30/2013 5:30 PM ET
Advancing Neuroscience: MRI Interventions, IMRIS and Tocagen Combine Technologies to Precisely Deliver Potential Cancer-Fighting Drug to Brain Tumors
PR Newswire - Thursday 05/30/2013 11:50 AM ET
IMRIS Announces US Patent for Microsurgical Robot Concept
PR Newswire - Wednesday 05/22/2013 2:00 PM ET
| TSE:IM | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | -- |
| Company | Last | Change |
|---|
Data is delayed by at least 15 min.